ABOUT THE STUDY Sample Clauses
ABOUT THE STUDY. Number of Study Participants Length of Study for Participants Eligibility to Participate in Another Drug Study Dosing Plan Study Process
ABOUT THE STUDY. Number of Study Participants Length of Study for Participants
ABOUT THE STUDY. The study has 4 parts (Part 1, Part 2, Part 3, and Part 4). To date, the in-clinic evaluations of Part 1, Part 2 (western population) and Part 3 are completed. You will be participating in Part 4 only. This consent document is limited to describing only those procedures and dosings in Part 4 of the study that you may undergo if you qualify for and agree to participate.
ABOUT THE STUDY. The study has up to 3 parts (Part 1, Part 2, and optional Part 3).